Tag: Keytruda biosimilar
Future Biosimilars: Upcoming Patent Expirations and Market Entry
Biosimilars are set to transform healthcare as major biologics like Keytruda and Eylea lose patent protection. With billions in savings on the horizon, learn how these complex drugs are entering the market and what it means for patients and providers.